MDSpire - Summary
From the Journals
Clinical Guidelines

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Share

Paula S. Kennedy-Newton, MSN, AGNP-C, from Duke Cancer Institute, presented a detailed exploration of neuroendocrine tumors (NETs) at JADPRO Live 2025. The session covered advancements in diagnosis, treatment, and patient management for this complex malignancy. NETs, arising from neuroendocrine cells, exhibit various grades, with significant implications for prognosis and treatment. Effective management involves multidisciplinary care, advanced imaging techniques, systemic therapies, and a focus on alleviating carcinoid symptoms while monitoring for disease progression.

Original Source(s)

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

  • by Paula S. Kennedy-Newton, MSN, AGNP-C

  • March 30, 2026

Related Content

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

“The results of our study show that tailoring the extent of radiotherapy according to how well the chemotherapy has worked to treat cancer in the lymph nodes leads to very low and reassuring recurrenc...

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies